InCor Heart Institute

• Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol Supplementation

  Recruiting, 80 people

• NCT04368819

  Collaborator, Phase 2/3, Status unknown, 40 people, 30 Apr 2020

• NCT04352465

  Collaborator, Phase 1/2, Status unknown, 42 people, 20 Apr 2020

• NCT04297839

  Collaborator, Phase 3, Suspended, 200 people, 6 Mar 2020

• NCT03943459

  Phase 3, Status unknown, 60 people, 9 May 2019

• NCT02592980

  Collaborator, Phase 4, Status unknown, 300 people, 30 Oct 2015

• NCT02574156

  Collaborator, Phase 3, Terminated, 500 people, 12 Oct 2015

• NCT01857999

  Phase 4, Completed, 21 people, 20 May 2013

Sources: clinicaltrials.gov